Prosecution Insights
Last updated: August 15, 2026

Genfit

7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Portfolio Summary

7
Total Pending OAs
5
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (29%)
5
Medium (71%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (29%)
§103 only3 (43%)
§102 only2 (29%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
71% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
14% of docket
1
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
OTTON, ALICIA L 1 65.0% +9.2%
NEWTON, CHAD A 1 38.0% +25.0%
FETTEROLF, BRANDON J 1 51.4% +17.1%
SABOUR, GHAZAL 1 37.8% +43.2%
LEE, ANDREW P 1 48.4% +23.3%
DHARITHREESAN, NIDHI 1 40.0% +35.1%
SITTON, JEHANNE SOUAYA 1 53.0% +48.0%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17849161 METHODS FOR DIAGNOSING AND EVALUATING NON-ALCOHOLIC STEATOHEPATITIS DHARITHREESAN, NIDHI 8d overdue
18250990 METHODS OF DIAGNOSTIC OF LIVER FIBROSIS SABOUR, GHAZAL

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17920260 ELAFIBRANOR FOR THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS LEE, ANDREW P 71d overdue
18569619 METHOD FOR NASH RISK ASSESSMENT IN PATIENTS HAVING A METABOLIC DISORDER NEWTON, CHAD A 43d overdue
17237789 QUANTITATIVE DETECTION OF MICRO-RNAS SITTON, JEHANNE SOUAYA 32d overdue
17849161 METHODS FOR DIAGNOSING AND EVALUATING NON-ALCOHOLIC STEATOHEPATITIS DHARITHREESAN, NIDHI 8d overdue
18289511 NITAZOXANIDE IN THE TREATMENT OF SEPSIS FETTEROLF, BRANDON J 4d overdue
18250990 METHODS OF DIAGNOSTIC OF LIVER FIBROSIS SABOUR, GHAZAL

Top Art Units

Art UnitApps
1699 1
3681 1
1626 1
1691 1
1686 1
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18573596 Unsaturated Hydroxamic Acid Derivatives and Their Use for the Treatment and Prevention of an Ammonia-Associated Disease or Disorder OTTON, ALICIA L 1699 §102 Non-Final OA Pending Dec 22, 2023
18569619 METHOD FOR NASH RISK ASSESSMENT IN PATIENTS HAVING A METABOLIC DISORDER NEWTON, CHAD A 3681 §103 Non-Final OA 43d overdue Pending Dec 13, 2023
18289511 NITAZOXANIDE IN THE TREATMENT OF SEPSIS FETTEROLF, BRANDON J 1626 §102 Final Rejection 4d overdue Pending Nov 03, 2023
18250990 METHODS OF DIAGNOSTIC OF LIVER FIBROSIS SABOUR, GHAZAL §101§103§112DP Non-Final OA Pending Apr 28, 2023
17920260 ELAFIBRANOR FOR THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS LEE, ANDREW P 1691 §103 Non-Final OA 71d overdue Pending Oct 20, 2022
17849161 METHODS FOR DIAGNOSING AND EVALUATING NON-ALCOHOLIC STEATOHEPATITIS DHARITHREESAN, NIDHI 1686 §101§103Other Non-Final OA 8d overdue Pending Jun 24, 2022
17237789 QUANTITATIVE DETECTION OF MICRO-RNAS SITTON, JEHANNE SOUAYA 1682 §103 Non-Final OA 32d overdue Pending Apr 22, 2021

Managing Genfit's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month